Multifactorial Analysis of Prognostic and Predictive Biomarkers in Triple Negative Breast Cancer Patients
Triple-negative breast cancer (TNBC) represents one of the most aggressive subtypes of breast cancer, characterized by the absence of key molecular targets including estrogen receptors (ER), progesterone receptors (PR), and HER2. This molecular profile significantly limits treatment modalities, esta...
Saved in:
| Main Authors: | V. N. Pavlov, M. F. Urmantsev, R. F. Gilmanova, J. A. Ismagilova, M. R. Bakeev |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bashkir State Medical University
2025-07-01
|
| Series: | Креативная хирургия и онкология |
| Subjects: | |
| Online Access: | https://www.surgonco.ru/jour/article/view/1086 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Status of Immune Checkpoint Inhibitors and Treatment Responsive Biomarkers for Triple‐Negative Breast Cancer
by: Xinran Wang, et al.
Published: (2025-05-01) -
Identification of circulating tumor cells marker genes as prognostic signature in triple-negative breast cancer
by: Jia Hu, et al.
Published: (2025-05-01) -
Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features
by: Florence Boissière-Michot, et al.
Published: (2024-12-01) -
Construction of a novel five programmed cell death-related gene signature as a promising prognostic model for triple negative breast cancer
by: Quanfeng Shao, et al.
Published: (2025-04-01) -
High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer
by: Yuling Xiao, et al.
Published: (2025-07-01)